The PolyM products also have the luxury now of having many more sets of experienced, professional, successful small molecule scientists reviewing the data and the products for possible tweaking. Not knocking the old products, but if they had a weakness that could be corrected, the joint team should have a pretty good chance of improving the performance and decreasing the bad side effects.
Hope the old "Sum of the parts..." theory holds true here.
News 
Market Data 
Discover 
AI
